Primus In News
Healthtech firms rush for D-Street debut
19-06-2025
Vivek Tandon, Vice President, Primus Partners, shares his view on the recent surge in healthtech IPOs in India. He highlights that the pandemic catalyzed investor interest in digital health infrastructure, paving the way for strong capital market activity in segments like telemedicine, diagnostics, and data-driven healthcare. Initiatives such as e-Sanjeevani and growing private sector innovation have further strengthened the outlook for healthtech companies going public.
Explore Related Insights
- Primus Partners, Data Safeguard Form Global Privacy & AI Alliance
- RBI’s liquidity, growth-supporting measures crucial for recovery from 2nd COVID wave: Experts
- COVID-19 impact on industry to last beyond June: ASSOCHAM survey
- The Rs 10 strategy and out-of-the-box distribution tactics that helped Lahori Zeera beat big cola brands
